Alliance Pharma plc (LON:APH - Get Free Report)'s stock price crossed above its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of GBX 40.93 ($0.51) and traded as high as GBX 49.95 ($0.63). Alliance Pharma shares last traded at GBX 46.40 ($0.58), with a volume of 943,356 shares.
Alliance Pharma Stock Performance
The company has a current ratio of 2.93, a quick ratio of 1.42 and a debt-to-equity ratio of 47.46. The firm's fifty day moving average price is GBX 45.91 and its 200-day moving average price is GBX 40.93. The firm has a market cap of £247.85 million, a price-to-earnings ratio of -764.17, a PEG ratio of 1.04 and a beta of 0.67.
Alliance Pharma Company Profile
(
Get Free Report)
Alliance Pharma plc operates as a pharmaceutical company in Europe, the Middle East, Africa, the Asia Pacific, China, and the Americas. The company acquires, markets, and distributes consumer healthcare and prescription medicine products. The company also offers medicines, medical devices, food supplements, and cosmetics.
Featured Stories
Before you consider Alliance Pharma, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Alliance Pharma wasn't on the list.
While Alliance Pharma currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Which stocks are likely to thrive in today's challenging market? Click the link below and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
